Control of Mycobacterium tuberculosis growth by activated natural killer cells

Clinical and Experimental Immunology

Volumn 168, Issue 1, 2012, Pages 142-152

  Guerra, C ^a   Johal, K ^a   Morris, D ^a   Moreno, S ^a   Alvarado, O ^a   Gray, D ^a   Tanzil, M ^a   Pearce, D ^a   Venketaraman, V ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Glutathione and innate immunity; HIV; Monocytes; Natural killer cells; Tuberculosis

Indexed keywords

ACETYLCYSTEINE; CD40 LIGAND; FAS LIGAND; GLUTATHIONE; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; CD40 LIGAND; FAS LIGAND PROTEIN; FEMALE; GLUTATHIONE; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; TUBERCULOSIS;

EID: 84857758249     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04552.x     Document Type: Article

References (23)

1. Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology 2010; 15:413-32.
2. Dutta NK, Mehra S, Kaushal D. A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. PLoS ONE 2010; 5:e10069.
3. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989; 257 (4 Pt 1): L163-73.
4. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999; 27:922-35.
5. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 2008; 300:423-30.
6. Venketaraman V, Dayaram YK, Amin AG etal. Role of glutathione in macrophage control of mycobacteria. Infect Immun 2003; 71:1864-71.
7. Venketaraman V, Dayaram YK, Talaue MT, Connell ND. Glutathione and nitrosoglutathione in macrophage defense against M. tuberculosis. Infect Immun 2005; 73:1886-94.
8. Dayaram YK, Talaue MT, Connell ND, Venketaraman V. Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione. J Bacteriol 2006; 188:1364-72.
9. Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V. Natural killer cells, glutathione, cytokines and innate immunity against Mycobacterium tuberculosis. J Interferon Cytokine Res 2008; 28:1-13.
10. Venketaraman V, Rodgers T, Linnares R etal. Tuberculosis immunity in healthy and HIV-infected subjects. AIDS Res Ther 2006; 3:5.
11. Venketaraman V, Millman AC, Salman M etal. Glutathione levels and immune responses in tuberculosis patients. Microb Pathog 2008; 44:255-61.
12. Yamauchi A, Bloom ET. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human cells. J Immunol 1993; 151:5535-44.
13. Brill KJ, Li Q, Larkin R etal. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 2001; 69:1755-65.
14. Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A. Human NK-cell receptors. Immunol Today 2000; 21:420-2.
15. Sivori S, Vitale M, Morelli L etal. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 1997; 186:1129-36.
16. Vitale M, Bottino C, Sivori S etal. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998; 12:2065-72.
17. Pende D, Parolini S, Pessino A etal. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999; 190:1505-16.
18. Bermudez LE, Wu M, Young LS. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect Immun 1995; 63:4099-104.
19. Cossarizza A, Stent G, Mussini C etal. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. AIDS 2000; 14:345-55.
20. Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996; 157:2909-15.
21. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178:669-74.
22. Carbone E, Ruggiero G, Terrazzano G etal. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997; 185:2053-60.
23. Subauste CS, Wessendarp M, Portilllo JA etal. Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients. J Infect Dis 2004; 189:61-70.